Bridge Therapeutics, Inc.

New Filing
CIK: 0001724287·Pharmaceuticals·DELAWARE·Filed: Dec 18, 2023
Total Offering

$1,500,000

Amount Sold

$321,000

Investors

22

First Sale

Oct 27, 2023

Offering Details

Type
Debt, Other: Optional conversion into equity at maturity
Exemptions
Rule 506(c)
Entity Type
Corporation
Non-Accredited Investors
No

Related Persons

NameRole
Timothy Grant Peara
Related Person
James Gregory Sullivan
Related Person
Elizabeth Kelley
Related Person
Joseph Patrick Mullin
Related Person
Jason Bailey
Related Person
Christopher Palutis
Related Person

Company

Bridge Therapeutics, Inc.

217 COUNTRY CLUB PARK, STE

BIRMINGHAM, AL, 35213

800-223-6949

SEC Filing

0001724287-23-000002

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
Bridge Therapeutics, Inc. Form D Filing — $1,500,000 | FilingFlow